Cannara Biotech Inc Cash Flow-to-Debt Ratio
Cannara Biotech Inc cash flow-to-debt ratio. Cannara Biotech Inc (LOVE) has a Cash Flow-to-Debt Ratio of 0.13x as of November 2025, meaning its operating cash flow of CA$7.96 Million could theoretically repay 0% of its total liabilities (CA$62.63 Million) in one year. Check LOVE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cannara Biotech Inc (2018–2025)
Cash flow-to-debt ratio of Cannara Biotech Inc from 2018 to 2025. Historical debt coverage capacity for Cannara Biotech Inc across 8 annual periods. Check cash flow quality index of Cannara Biotech Inc to evaluate the quality of earnings relative to operating cash generation.
Cannara Biotech Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Cannara Biotech Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Cannara Biotech Inc. For the full cash flow conversion analysis, see LOVE cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CA$20.01 Million | CA$66.43 Million | ▲ +88.3% |
| 2024 | 0.16x | CA$10.68 Million | CA$66.77 Million | ▲ +67.2% |
| 2023 | 0.10x | CA$5.91 Million | CA$61.78 Million | ▲ +192.7% |
| 2022 | -0.10x | CA$-6.08 Million | CA$58.88 Million | ▼ -37.7% |
| 2021 | -0.07x | CA$-2.09 Million | CA$27.91 Million | ▲ +86.7% |
| 2020 | -0.57x | CA$-9.32 Million | CA$16.49 Million | ▼ -38.7% |
| 2019 | -0.41x | CA$-7.41 Million | CA$18.17 Million | ▼ -149.7% |
| 2018 | -0.16x | CA$-2.30 Million | CA$14.12 Million | — |